Characteristic | Good outcome N = 187 | Poor outcome N = 197 | P value |
---|---|---|---|
Female gender | 46 (25%) | 55 (28%) | 0.6 |
Mean age (±SD) | 60 ± 12 | 67 ± 12 | <0.0001 |
OHCA | 173 (93%) | 172 (87%) | 0.2 |
Cardiac etiology | 165 (88%) | 138 (70%) | <0.0001 |
VF rhythm | 169 (90%) | 114 (58%) | <0.0001 |
Patients treated with propofol | 174 (93%) | 171 (87%) | 0.05 |
Mean propofol dose (mg/kg/h ± SD) | 2.9 ± 1.6 | 3.2 ± 9.0 | 0.6 |
Patients treated with midazolam | 74 (40%) | 79 (40%) | 1.0 |
Mean midazolam dose (μg/kg/h ± SD) | 93 ± 65 | 112 ± 85 | 0.2 |
Patients treated with morphine | 70 (37%) | 61 (31%) | 0.7 |
Mean morphine dose (μg/kg/h ± SD) | 18 ± 13 | 21 ± 16 | 0.3 |
SSEP performed | 39 (21%) | 139 (71%) | <0.0001 |
Bilaterally absent SSEP at 72 hours | 7 (4%) | 65 (33%) | <0.0001 |
Unfavorable EEG at 24 hours | 0/178 (0%)a | 52/179 (29%)a | <0.0001 |
Favorable EEG at 12 hours | 63/123 (51%)b | 15/125 (12%)b | <0.0001 |